Pfizer agrees to pay $35 million to settle US antitrust claims over Lipitor
MLex Summary: Pfizer agreed to pay $35 million to resolve US antitrust claims filed by end-payors of Lipitor accusing it of unlawfully delaying market entry for a generic competitor. The deal...To view the full article, register now.
Already a subscriber? Click here to view full article